Smart Pills Market By Application (product (capsule Endoscopy And Drug Delivery), Tools, Patient Monitoring Software) - Global Industry Analysis And Forecast To 2023
Published On : June 2022 Pages : 190 Category: Medical Devices Report Code : HC061028
Industry Outlook and Trend Analysis
The Smart Pills Market was worth USD 1.61 billion in 2017 and is expected to reach approximately USD 6.19 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 16.14% during the forecast period. Smart pills have risen as a progressive mechanical advancement, crossing over any barrier between computerized innovation and medicinal services. With the advent of these medicinal services cum-mechanical devices has empowered tending to taking off interest for better observing and diagnostics. Smart pills have now turned out to be standard system for non-intrusive determination with respect to motility issue. Doctors lean towards smart pills as they empower on-going patient observing by means of remote controlling alternatives.
Drivers & Restrains
Interest for advanced drug delivery systems with advantages, for example, ideal utilization of dynamic pharmaceutical fixing, decreased dose recurrence, negligible antagonistic/symptoms, directed medication conveyance, and more secure transporter is driving the market for smart pills. Incorporation of imaginative medications, therapeutic gadgets, and propelled advancements is relied upon to assume an essential part in additionally boosting the market over the figure time frame. Patients with unending illnesses who need to take after a particular dosage of medicine at the target site are relied upon to frame a vast client base for advanced drug delivery products. Popularity for negligibly intrusive surgeries has offered ascend to innovative strategies, for example, capsule endoscopy.
Regional Outlook and Trend Analysis
North America will keep on being the most profitable market for smart pills, for the most part determined by variables, for example, quick administrative endorsement of new items, developing instances of colorectal malignancy, and mechanical headways in the social insurance segment. The market in Asia-Pacific excluding Japan (APEJ) is anticipated to enlist a strong development through 2026, nearly trailing North America. Mandatory healthcare insurance provisions and developing commonness of gastrointestinal issue and stomach tumour are essential elements affecting the market development in APEJ. High predominance of target issue combined with expanding government bolster is additionally anticipated that would clear development open doors for smart pills market in APEJ.
Competitive Insights
The leading players in the market are Proteus Digital Health, Olympus Corporation, Medtronic PLC, Medisafe and others. Many Key players are depending on methods, for example, agreements & joint ventures, collaborations, and advancements to build the visibility of their products and fortify their product portfolios.
The Smart Pills Market is segmented as follows-
By Application:
- Product
- Capsule Endoscopy
- Drug Delivery
- Tools
- Patient Monitoring Software
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Smart Pills Market, By Application, Estimates and Forecast, 2014-2023 ($Million)
· Product
o Capsule Endoscopy
o Drug Delivery
· Tools
· Patient Monitoring Software
· Smart Pills Market, By Region, Estimates and Forecast, 2014-2023 ($Million)
· North America
§ North America Smart Pills Market, By Country
o U.S. Smart Pills Market
o Canada Smart Pills Market
o Mexico Smart Pills Market
· Europe
§ Europe Smart Pills Market, By Country
o Germany Smart Pills Market
o UK Smart Pills Market
o France Smart Pills Market
o Russia Smart Pills Market
o Italy Smart Pills Market
o Rest of Europe Smart Pills Market
· Asia-Pacific
§ Asia-Pacific Smart Pills Market, By Country
o China Smart Pills Market
o Japan Smart Pills Market
o South Korea Smart Pills Market
o India Smart Pills Market
o Southeast Asia Smart Pills Market
o Rest of Asia-Pacific Smart Pills Market
· South America
§ South America Smart Pills Market
o Brazil Smart Pills Market
o Argentina Smart Pills Market
o Columbia Smart Pills Market
o South Africa Smart Pills Market
o Rest of South America Smart Pills Market
· Middle East and Africa
§ Middle East and Africa Smart Pills Market
o Saudi Arabia Smart Pills Market
o UAE Smart Pills Market
o Egypt Smart Pills Market
o Nigeria Smart Pills Market
o South Africa Smart Pills Market
o Rest of MEA Smart Pills Market
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
5. Smart Pills Market, By Application
5.1. Introduction
5.2. Global Smart Pills Sales, Revenue and Market Share by Application (2017-2027)
5.2.1. Global Smart Pills Sales and Sales Share by Application (2017-2027)
5.2.2. Global Smart Pills Revenue and Revenue Share by Application (2017-2027)
5.3. Product
5.3.1. Global Product Sales and Growth Rate (2017-2027)
5.3.2. Global Product Sales and Growth Rate By Type (2017-2027)
5.3.3. Capsule Endoscopy
5.3.3.1. Global Capsule Endoscopy Sales and Growth Rate By Type (2017-2027)
5.3.4. Drug Delivery
5.3.4.1. Global Drug Delivery Sales and Growth Rate By Type (2017-2027)
5.4. Tools
5.4.1. Global Tools Sales and Growth Rate (2017-2027)
5.5. Patient Monitoring Software
5.5.1. Global Patient Monitoring Software Sales and Growth Rate (2017-2027)
6. Smart Pills Market, By Region
6.1. Introduction
6.2. Global Smart Pills Sales, Revenue and Market Share by Regions
6.2.1. Global Smart Pills Sales by Regions (2017-2027)
6.2.2. Global Smart Pills Revenue by Regions (2017-2027)
6.3. North America Smart Pills by Countries
6.3.1. North America Smart Pills Sales and Growth Rate (2017-2027)
6.3.2. North America Smart Pills Revenue and Growth Rate (2017-2027)
6.3.3. North America Smart Pills Sales by Countries (2017-2027)
6.3.4. North America Smart Pills Revenue (Million USD) by Countries (2017-2027)
6.3.5. U.S.
6.3.5.1. United States Smart Pills Sales and Growth Rate (2017-2027)
6.3.5.2. United States Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.3.6. Canada
6.3.6.1. Canada Smart Pills Sales and Growth Rate (2017-2027)
6.3.6.2. Canada Smart Pills Sales (Millions USD) and Growth Rate (2017-2027)
6.3.7. Mexico
6.3.7.1. Mexico Smart Pills Sales and Growth Rate (2017-2027)
6.3.7.2. Mexico Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.4. Europe Smart Pills by Countries
6.4.1. Europe Smart Pills Sales and Growth Rate (2017-2027)
6.4.2. Europe Smart Pills Revenue and Growth Rate (2017-2027)
6.4.3. Europe Smart Pills Sales by Countries (2017-2027)
6.4.4. Europe Smart Pills Revenue (Million USD) by Countries (2017-2027)
6.4.5. Germany
6.4.5.1. Germany Smart Pills Sales and Growth Rate (2017-2027)
6.4.5.2. Germany Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.6. UK
6.4.6.1. UK Smart Pills Sales and Growth Rate (2017-2027)
6.4.6.2. UK Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.7. France
6.4.7.1. France Smart Pills Sales and Growth Rate (2017-2027)
6.4.7.2. France Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.8. Russia
6.4.8.1. Russia Smart Pills Sales and Growth Rate (2017-2027)
6.4.8.2. Russia Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.9. Italy
6.4.9.1. Italy Smart Pills Sales and Growth Rate (2017-2027)
6.4.9.2. Italy Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.4.10. Rest of Europe
6.4.10.1. Rest of Europe Smart Pills Sales and Growth Rate (2017-2027)
6.4.10.2. Rest of Europe Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.5. Asia-Pacific
6.5.1. Asia-Pacific Smart Pills Sales and Growth Rate (2017-2027)
6.5.2. Asia-Pacific Smart Pills Revenue and Growth Rate (2017-2027)
6.5.3. Asia-Pacific Smart Pills Sales by Countries (2017-2027)
6.5.4. Asia-Pacific Smart Pills Revenue (Million USD) by Countries (2017-2027)
6.5.5. China
6.5.5.1. China Smart Pills Sales and Growth Rate (2017-2027)
6.5.5.2. China Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.6. Japan
6.5.6.1. Japan Smart Pills Sales and Growth Rate (2017-2027)
6.5.6.2. Japan Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.6.3.
6.5.7. Korea
6.5.7.1. Korea Smart Pills Sales and Growth Rate (2017-2027)
6.5.7.2. Korea Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.8. India
6.5.8.1. India Smart Pills Sales and Growth Rate (2017-2027)
6.5.8.2. India Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.9. Southeast Asia
6.5.9.1. Southeast Asia Smart Pills Sales and Growth Rate (2017-2027)
6.5.9.2. Southeast Asia Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.5.10. Rest of Asia-Pacific
6.5.10.1. Rest of Asia-Pacific Smart Pills Sales and Growth Rate (2017-2027)
6.5.10.2. Rest of Asia-Pacific Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.6. South America
6.6.1. South America Smart Pills Sales and Growth Rate (2017-2027)
6.6.2. South America Smart Pills Revenue and Growth Rate (2017-2027)
6.6.3. South America Smart Pills Sales by Countries (2017-2027)
6.6.4. South America Smart Pills Revenue (Million USD) by Countries (2017-2027)
6.6.5. Brazil
6.6.5.1. Brazil Smart Pills Sales and Growth Rate (2017-2027)
6.6.5.2. Brazil Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.6. Argentina
6.6.6.1. Argentina Smart Pills Sales and Growth Rate (2017-2027)
6.6.6.2. Argentina Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.7. Columbia
6.6.7.1. Columbia Smart Pills Sales and Growth Rate (2017-2027)
6.6.7.2. Columbia Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.6.8. Rest of South America
6.6.8.1. Rest of South America Smart Pills Sales and Growth Rate (2017-2027)
6.6.8.2. Rest of South America Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.7. Middle East and Africa
6.7.1. Middle East and Africa Smart Pills Sales and Growth Rate (2017-2027)
6.7.2. Middle East and Africa Smart Pills Revenue and Growth Rate (2017-2027)
6.7.3. Middle East and Africa Smart Pills Sales by Countries (2017-2027)
6.7.4. Middle East and Africa Smart Pills Revenue (Million USD) by Countries (2017-2027)
6.7.5. Saudi Arabia
6.7.5.1. Saudi Arabia Smart Pills Sales and Growth Rate (2017-2027)
6.7.5.2. Saudi Arabia Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.6. United Arab Emirates
6.7.6.1. United Arab Emirates Smart Pills Sales and Growth Rate (2017-2027)
6.7.6.2. United Arab Emirates Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.7. Egypt
6.7.7.1. Egypt Smart Pills Sales and Growth Rate (2017-2027)
6.7.7.2. Egypt Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.8. Nigeria
6.7.8.1. Nigeria Smart Pills Sales and Growth Rate (2017-2027)
6.7.8.2. Nigeria Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.9. South Africa
6.7.9.1. South Africa Smart Pills Sales and Growth Rate (2017-2027)
6.7.9.2. South Africa Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
6.7.10. Rest of Middle East and Africa
6.7.10.1. Rest of Middle East and Africa Smart Pills Sales and Growth Rate (2017-2027)
6.7.10.2. Rest of Middle East and Africa Smart Pills Revenue (Millions USD) and Growth Rate (2017-2027)
7. Company Profiles
7.1. Medtronic
7.1.1. Business Overview
7.1.2. Product Portfolio
7.1.3. Strategic Developments
7.1.4. Sales, Revenue and Market Share
7.2. Proteus Digital Health (Subsidiary of Harbin Gloria Pharmaceuticals Company Ltd.)
7.2.1. Business Overview
7.2.2. Product Portfolio
7.2.3. Strategic Developments
7.2.4. Sales, Revenue and Market Share
7.3. CapsoVision, Inc.
7.3.1. Business Overview
7.3.2. Product Portfolio
7.3.3. Strategic Developments
7.3.4. Sales, Revenue and Market Share
7.4. Olympus Corporation
7.4.1. Business Overview
7.4.2. Product Portfolio
7.4.3. Strategic Developments
7.4.4. Sales, Revenue and Market Share
7.5. Medisafe
7.5.1. Business Overview
7.5.2. Product Portfolio
7.5.3. Strategic Developments
7.5.4. Sales, Revenue and Market Share
7.6. Acamp
7.6.1. Business Overview
7.6.2. Product Portfolio
7.6.3. Strategic Developments
7.6.4. Sales, Revenue and Market Share
7.7. Boston Scientific Corporation
7.7.1. Business Overview
7.7.2. Product Portfolio
7.7.3. Strategic Developments
7.7.4. Sales, Revenue and Market Share
7.8. Cerner Corporation
7.8.1. Business Overview
7.8.2. Product Portfolio
7.8.3. Strategic Developments
7.8.4. Sales, Revenue and Market Share
7.9. GE Healthcare
7.9.1. Business Overview
7.9.2. Product Portfolio
7.9.3. Strategic Developments
7.9.4. Sales, Revenue and Market Share
7.10. Fujifilm Holdings Corporation
7.10.1. Business Overview
7.10.2. Product Portfolio
7.10.3. Strategic Developments
7.10.4. Sales, Revenue and Market Share
8. Global Smart Pills Market Competition, by Manufacturer
8.1. Global Smart Pills Sales and Market Share by Manufacturer (2017-2017)
8.2. Global Smart Pills Revenue and Market Share by Manufacturer (2017-2017)
8.3. Global Smart Pills Price by Manufacturer (2017-2017)
8.4. Top 5 Smart Pills Manufacturer Market Share
8.5. Market Competition Trend
9. Smart Pills Market Forecast (2027-2023)
9.1. Global Smart Pills Sales, Revenue (Millions USD) and Growth Rate (2027-2023)
9.2. Smart Pills Market Forecast by Regions (2027-2023)
9.2.1. North America Smart Pills Market Forecast (2027-2023)
9.2.1.1. United States Smart Pills Market Forecast (2027-2023)
9.2.1.2. Canada Smart Pills Market Forecast (2027-2023)
9.2.1.3. Mexico Smart Pills Market Forecast (2027-2023)
9.2.2. Europe Smart Pills Market Forecast (2027-2023)
9.2.2.1. Germany Smart Pills Market Forecast (2027-2023)
9.2.2.2. United Kingdom Smart Pills Market Forecast (2027-2023)
9.2.2.3. France Smart Pills Market Forecast (2027-2023)
9.2.2.4. Russia Smart Pills Market Forecast (2027-2023)
9.2.2.5. Italy Smart Pills Market Forecast (2027-2023)
9.2.2.6. Rest of the Europe Smart Pills Market Forecast (2027-2023)
9.2.3. Asia-Pacific Smart Pills Market Forecast (2027-2023)
9.2.3.1. China Smart Pills Market Forecast (2027-2023)
9.2.3.2. Japan Smart Pills Market Forecast (2027-2023)
9.2.3.3. Korea Smart Pills Market Forecast (2027-2023)
9.2.3.4. India Smart Pills Market Forecast (2027-2023)
9.2.3.5. Southeast Asia Smart Pills Market Forecast (2027-2023)
9.2.3.6. Rest of Asia-Pacific Smart Pills Market Forecast (2027-2023)
9.2.4. South America Smart Pills Market Forecast (2027-2023)
9.2.4.1. Brazil Smart Pills Market Forecast (2027-2023)
9.2.4.2. Argentina Smart Pills Market Forecast (2027-2023)
9.2.4.3. Columbia Smart Pills Market Forecast (2027-2023)
9.2.4.4. Rest of South America Smart Pills Market Forecast (2027-2023)
9.2.5. Middle East and Africa Smart Pills Market Forecast (2027-2023)
9.2.5.1. Saudi Arabia Smart Pills Market Forecast (2027-2023)
9.2.5.2. UAE Smart Pills Market Forecast (2027-2023)
9.2.5.3. Egypt Smart Pills Market Forecast (2027-2023)
9.2.5.4. Nigeria Smart Pills Market Forecast (2027-2023)
9.2.5.5. South Africa Smart Pills Market Forecast (2027-2023)
9.2.5.6. Rest of MEA Smart Pills Market Forecast (2027-2023)
9.3. Smart Pills Market Forecast by Application (2027-2023)
9.3.1. Global Smart Pills Sales Forecast by Application (2027-2023)
9.3.2. Global Smart Pills Sales Market Share Forecast by Application (2027-2023)
List of Tables
*You can glance through the list of Tables and Figures when you view the sample copy of Smart Pills Market.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|